ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

New Biomedical Research Panel Accepts Broad Mandate. May Suggest Separate Health Dept.

February 28, 1975

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

AMA Anti-Tobacco, Stop-Smoking Program Uses TV Marketing

April 15, 1994